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Summary
Background Cross-sectional and longitudinal reports show that obese adults have more
asthma than non-obese adults. A proposed mechanism is via effects of adipokines (leptin
and adiponectin) on the immune system.
Objective We wished to measure the associations of asthma and other atopic diseases with
serum adipokine levels and to find whether the associations with asthma were strong
enough to rule out the possibility that they are secondary to the association of fatness
measures with asthma.
Methods The Global Asthma and Allergy Network of Excellence (GA2LEN) clinical follow-
up survey is a clinical survey, embedded in a larger multi-centre cross-sectional postal
survey, involving, with a case/control design, enrichment of the sample with subjects with
asthma and chronic rhinosinusitis (CRS). We recorded serum leptin or adiponectin in 845
men and 1110 women in 15 centres and also anthropometric measures of fatness includ-
ing body mass index and waist/hip ratio, current asthma, and specific skin prick and IgE
sensitisation. We used inverse sampling-probability-weighted rank and regression statis-
tics to measure population associations of disease outcomes with adipokines in males and
females, adjusting for confounders (area, age, smoking history, and number of elder sib-
lings) and also mutually adjusting associations with adipokines and fatness measures.
Results One thousand nine hundred and fifty-five subjects aged 16–77 years had infor-
mation on leptin or adiponectin levels. Leptin and leptin/adiponectin ratio were positively
associated with the level of asthma, especially in females (Somers’ D of leptin by asthma
score, 0.20; 95% CI, 0.08–0.30; P = 0.00079). These associations were attenuated after
adjusting for confounders and became non-significant after additionally adjusting for
fatness measures and multiple comparisons.
Conclusions and Clinical Relevance Asthma levels are positively associated with serum
leptin. However, we cannot rule out the possibility that this association is secondary to
associations of both with fatness measures.
Keywords adiponectin, asthma, IgE sensitivity, leptin, nasal allergy, obesity, skin prick
sensitivity
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Introduction
Cross-sectional and longitudinal reports show that
obese adults have more asthma than their non-obese
contemporaries [1], but the relationship of atopy with
obesity is less clear [2–4]. Several mechanisms have
been proposed to explain the relationship of asthma
symptoms with obesity, including direct mechanical
effects, gastro-oesophageal reflux, perturbation of sex
hormone levels, abnormal insulin handling, common
genetic predisposition [5, 6], and the role of adipocyte-
derived hormones (in particular leptin and adiponectin)
[7].
Leptin is a pro-inflammatory cytokine, structurally
related to interleukin-6 (IL-6), that controls food intake
and energy expenditure and is raised in those who are
obese [8]. The overall effect on T memory cells is to
increase Th-1 responses and decrease Th-2 responses
[7]. Adiponectin, which is lower in those who are obese,
is considered to have an overall anti-inflammatory
action, possibly by counteracting the production and
effects of cytokines such as TNF-a, IL-6 and nuclear
factor -KB [7].
To date, large-scale epidemiological studies that have
examined the relationship of asthma with adipokines in
adults [9–12] show inconsistent relationships that,
in some studies, appear gender specific [9, 11]. In the
Dunedin cohort [11], asthma symptoms were not associ-
ated with leptin levels in men or in women, but men
(not women) with higher levels of adiponectin had
lower exhaled nitric oxide levels. Measures of fatness
are highly correlated with adipokine levels, and
researchers have used different approaches to untangle
their relative effects, including mutual adjustment, and
examination of the effects of adipokine in thin and
then in fat individuals. No clear picture has emerged to
date, and to our knowledge, only one population-based
epidemiological study has reported these relationships
with allergic sensitisation as measured by skin prick
tests. That study suggested increased risk of sensitisat-
ion to any common environmental aeroallergen with
higher leptin levels in young adults [13] in Germany.
The aim of this report is to describe the cross-sec-
tional association of obesity and adipokines with
asthma in a large sample of men and women living in
Europe who took part in the Global Asthma and Allergy
Network of Excellence (GA2LEN) epidemiological
survey.
Materials and methods
Study design, setting, and participants
A representative sample of adults aged 20–75 years,
living in 25 centres in Europe, took part in a postal
survey asking about symptoms of asthma and chronic
rhinosinusitis (CRS). Eighteen centres in 11 countries
invited a sample of responders to the postal survey for
a nested clinical follow-up. Invitation to follow-up was
dependent on symptoms reported at the postal survey
and aimed to recruit representative samples of partici-
pants in four postal survey disease groups: (1) asthma
and CRS, (2) asthma (but no CRS), (3) CRS (but no
asthma), and (4) controls (neither asthma nor CRS). The
postal survey was carried out from October 2007 to
December 2008, and the clinical surveys from Septem-
ber 2008 to January 2010. The methods, response, and
results to the postal survey have been reported [14, 15].
Information collected
After completion of an interviewer-administered ques-
tionnaire, height, weight, waist circumference, and hip
circumference were recorded, and body mass index
(BMI), waist/hip ratio, and waist/height ratio were cal-
culated. Skin prick tests were taken to a panel of indoor
allergens (Dermatophagoides pteronyssinus, Dermato-
phagoides farinae and Blattella), pets (cat, dog), pollens
(grass mix, Timothy grass, Artemisia, Parietaria, olive.
birch), and mould (Alternaria alternata). Non-fasting
blood samples were taken and serum was measured for
serum-specific IgE to grass (ImmunoCAP; Thermo
Fisher, Uppsala, Sweden) in a single laboratory
[Rijksinstituut voor Volksgezondheid en Milieu (RIVM),
Amsterdam, Netherlands]. IgE sensitisation to Timothy
grass was considered present when serum measures
were > 0.35 kU/L, and SPTs were positive if the mean
wheal diameter was > 0 mm [16]. Participants with a
positive negative control (saline) or a negative positive
control (histamine dihydrochloride 10 mg/mL) were
excluded. From the participants with serum samples in
each case status group in each centre, we measured
adipokines on the full number of participants or on a
subsample of 44 (whichever was less), because of cost
constraints. Serum leptin and adiponectin were mea-
sured using a MULTI-ARRAY assay system (Meso
Scale Discovery, Gaithersburg, MD, USA) in all avail-
able samples from participants with asthma and partici-
pants with CRS, and a random sample of participants
with neither condition in a single laboratory (Imperial
College, London). Sera were used neat for leptin and in
1 : 1000 dilution for the adiponectin assay. The lower
limits of detection were 0.001 pg/mL for leptin and
85 pg/mL for adiponectin, and measurements below
these were recoded to the detectability limits. Three
centres (Krakow, Poland; Skopje, Macedonia; Palermo,
Italy) had insufficient serum samples for adipokine
measures.
Asthma was defined as reporting ever having asthma
and at least one of the following symptoms in the last
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12 months: (1) wheeze or whistling in the chest or (2)
waking with chest tightness or (3) waking with short-
ness of breath or (4) waking with an attack of cough-
ing. The European Community Respiratory Health
Survey (ECRHS) asthma score (on a scale from 0 to 5)
was derived by summing responses to questions on (1)
wheeze with breathlessness, (2) chest tightness, (3)
attack of shortness of breath (SOB) coming on at rest,
(4) SOB after exercise, and (5) being woken by SOB
[17].
Allergic rhinitis was defined as a positive response to
the question: ‘Do you have any nasal allergies
including hayfever?’
Statistical methods
Full statistical methods are detailed in the online sup-
porting information.
The association of asthma, nasal allergies, serum IgE
to Timothy grass, positive skin prick tests (SPT) to
house dust mite (positive SPT to either of Dermato-
phagoides pteronyssinus or Dermatophagoides farinae),
positive SPT to Timothy grass, and positive SPT to any
of the allergens tested with three adipokine measures
[leptin, adiponectin, leptin/adiponectin ratio (LAR)] and
four anthropometric measures of fatness (BMI, waist
circumference, waist/hip ratio, and waist/height ratio)
was examined separately in men and in women using
Somers’ D [18, 19]. Somers’ D is a rank statistic (lying
between 1 and 1) representing the risk of individuals
with the outcome of interest (e.g. asthma, nasal aller-
gies) having a higher predictor level (e.g. leptin, BMI)
compared with those without the outcome. It has been
used here because it is suitable for both binary out-
comes and for the asthma score, it can be determined
within strata specified by confounders, and it is resis-
tant to the extreme effects of outliers. A Somers’ D of
0.1 in the relationship of asthma with leptin implies
that it is 10% more likely that asthmatics have higher
leptin levels than non-asthmatics than the other way
round (that is, compared with the likelihood that non-
asthmatics have higher leptin levels than asthmatics).
We used two propensity scores to adjust the analysis
[20]. The first propensity score adjusted for area, age,
smoking status, pack years of smoking, and number of
elder siblings, and the second propensity score, in addi-
tion, adjusted for fatness measures (when examining
associations with adipokine levels) or adipokine levels
(when examining associations with fatness measures).
To allow for multiple comparisons, we applied the Si-
mes–Benjamini–Hochberg procedure [21] to generate Q-
values [19] for the 98 P-values for Somers’ D for trend
(seven outcomes 9 seven exposures 9 two genders) for
each of the three adjustments [unadjusted, propensity
score (1) adjusted and propensity score (2) adjusted].
These Q-values are equivalent to the lowest false dis-
covery rate (FDR) that could be set to reject the null
hypothesis and are also known as ‘adjusted P-values’.
As participants in the clinical survey were initially
recruited from postal survey responders using case–con-
trol selection procedures, analyses were weighted using
sampling-probability weights. The associations pre-
sented are estimates of those that we would expect to
find in postal survey responders, had they all been
assayed for adipokines in the clinical survey. In Poland,
Sweden and UK, there were small numbers of subjects
in some case groups, and to avoid some individuals
having extreme weights, subjects from centres have
been combined to form multi-centre areas (Sweden, UK
and Poland).
Results
Figure 1 details the selection of the sample for these
analyses. Three thousand five hundred and five subjects
from 18 centres contributed data to the GA2LEN fol-
low-up survey. Of these, 55 had unknown gender or
questionnaire age either unknown or below 16 years,
and a further 192 were in three centres (Palermo, Kra-
kow and Skopje) which were not included in measure-
ment of either leptin or adiponectin. One thousand
three hundred and three subjects in the remaining 15
centres had no measurements of either leptin or adipo-
nectin, because the adipokine study was a nested-nested
study inside the GA2LEN follow-up survey, which in
turn was nested in the GA2LEN postal survey. Leptin or
adiponectin levels were therefore available on a sub-
sample of 1955 subjects of known gender (845 men and
1110 women) aged 16 years or over in 15 centres in
nine countries. Further descriptive data on this sample
are given in Tables 1 and 2. Note that, in some centres
in some case groups, there were < 44 participants per
case status group per centre who also had serum
samples.
Figure 2 (duplicated in online Figure S2) shows the
confounder-adjusted associations. (See online Figures
S1 and S3, for unadjusted and mutually adjusted asso-
ciations, respectively.) In women (but not men), asthma
was positively associated with measure of fatness (BMI
P = 0.38, waist circumference P = 0.079, waist/hip ratio
P = 0.052, waist/height ratio P = 0.031). In both men
and women, higher asthma score was positively associ-
ated with fatness measures (in women, BMI P = 0.025,
waist circumference P = 0.028, waist/hip ratio
P = 0.049, waist/height ratio P = 0.0065; in men, BMI
P = 0.085, waist circumference P = 0.38, waist/hip ratio
P = 0.26, waist/height ratio P = 0.095). In both men
and women, there was evidence that higher asthma
score was associated with higher leptin and leptin/
adiponectin ratio (in women, leptin P = 0.0055,
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adiponectin P = 0.27, leptin/adiponectin ratio P = 0.03;
in men, leptin P = 0.082, adiponectin P = 0.85, leptin/
adiponectin ratio P = 0.3). However, allowing for multi-
ple comparisons, none of these associations are present
at adjusted P < 0.2. No clear associations were observed
for nasal allergies, IgE sensitisation to Timothy grass, or
positive skin prick tests.
The full set of Somers’ D statistics for overall trend is
given in the online repository (online Figures S1–S3).
Figure S1 confirms that the ECRHS 5-point asthma
score possibly has positive unadjusted associations with
leptin and leptin/adiponectin ratio, at least in females,
even after allowing for multiple comparisons (adjusted
P < 0.10). However, Figure S3 confirms that, after
mutual adjustment and correction for multiple compari-
sons, all adjusted P-values are non-significant.
Table 3 details the change in association between the
ECRHS 5-point asthma score and the three adipokine
and four fatness measures, when we adjusted first for
age, sex and smoking history [‘propensity-adjusted (1)’]
Postal survey to representative sample of adults aged 18–75
(~3000 per centre)
22 centres in 13 countries
Total responders = 59,703
Responders to postal survey invited for clinical assessment 
Symptom information collected, blood taken, serum stored
(within each centre, up to 120 with asthma, 120 with CRS, 40 with asthma and CRS, 120 controls)
18 centres in 12 countries
Total n = 3505 (3197 with serum sample)
3 centres did not follow protocol fully
1 centre did not take part in clinical follow-up
3 centres (Palermo, Krakow, Skopje) in which 
adipokines were not measured, n = 192
15 centres in 9 countries, n = 3450 (3163 with serum sample)
By centre, samples selected for testing for adipokines (to test total of ~2000)
All samples from those with asthma and CRS
All samples from those with asthma (or random sample if >44 serum samples in this case group within a centre)
All samples from those with CRS (or random sample if >44 serum samples in this case group within a centre)
All samples from controls (or random sample if >44 serum samples in this case group within a centre)
Leptin and/or adiponectin measures available and linked to health information for: 
532 with asthma only
522 with CRS only
316 with asthma and CRS 
585 with neither asthma nor CRS
Reweighting procedure so that results represent associations that would have 
existed in the 15 centres (9 countries) , had all those who responded to postal survey 
had clinical measures and serum leptin and adiponectin measured
Missing gender, missing age, or age<16, n = 55
Fig. 1. Selection of the sample for analysis from the subjects in the GA2LEN clinical survey. GA2LEN, Global Asthma and Allergy Network of
Excellence.
Table 1. Number of participants in the clinical study and with cyto-
kine measures by case status in each study area
Study area Control Asthma CRS
Asthma
& CRS Total
Sweden (Umea,
Uppsala, Gothenburg,
Stockholm)
147 176 154 139 616
Helsinki 46 39 28 12 125
Odense 42 45 44 39 170
Poland (Lodz,
Katowice*)
61 30 57 16 164
UK (London,
Southampton)
50 59 34 16 159
Amsterdam 43 43 44 10 140
Ghent 64 21 46 16 147
Brandenburg 44 43 44 14 145
Duisburg 44 32 27 17 120
Coimbra 44 44 44 37 169
Total 585 532 522 316 1955
*No subjects in Krakow had data on leptin or adiponectin.
CRS, chronic rhinosinusitis.
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and additionally for fatness measures (in the case of
adipokines) and for adipokines (in the case of fatness
measures) [‘propensity-adjusted (2)’]. We see that
adjustment attenuates the trend and widens the confi-
dence intervals, with the result that we cannot disen-
tangle the independent effects of adipokines (on the
one hand) and fatness measures (on the other), although
both fatness measures and adipokines predict asthma
score. This attenuation through mutual adjustment is
not surprising, in view of the high level of correlation,
within study areas and genders, between adipokine
measures and fatness measures. (See online Table S1,
which gives the within-area Somers’ D statistics of each
fatness measure with respect to each adipokine mea-
sure, showing that, in both males and females, fatness
measures are strongly positively associated with leptin
and leptin/adiponectin ratio and less strongly
negatively associated with adiponectin.)
In a post hoc analysis, we examined the association
of ECRHS asthma score with adipokine levels within
each BMI group (Fig. 3). The number of participants
with BMI < 20 was small. There was some suggestion
that an association of ECRHS asthma score with the
leptin/adiponectin ratio was present even in women
who were underweight (P = 0.001) or normal weight
(P = 0.13). However, confidence intervals are wide, and
we cannot exclude that these observations arise from
multiple subgroup analyses.
In another post hoc analysis, we measured the
within-area associations between asthma (and asthma
score) and the adipokine and fatness measures, in atop-
ics and non-atopics (atopy was defined as positive SPT
to at least one of the tested allergens). This was carried
out using the unadjusted (see online Figures S4 and S5)
and propensity-adjusted Somers’ D statistics of predic-
tors (associations with asthma score shown in Fig. 4).
We see little evidence of differences in these associa-
tions in atopics and non-atopics, although the confi-
dence intervals are wider, because of the smaller
sample sizes.
Discussion
In this large multi-centre cross-sectional study, we pro-
vide further evidence that obesity and leptin are associ-
ated with asthma, but not allergy, in adults. Leptin and
obesity measures are correlated, and we could not dem-
onstrate independent associations of either with asthma.
Our post hoc observation that the higher leptin/adipo-
nectin ratio is associated with more symptoms in
women with low and normal BMI may suggest inde-
pendent associations with adipokines, but this may
have arisen by chance, due to the large number of
statistical tests that we have conducted.
Previous epidemiological studies in adults examining
the relationship of asthma with leptin have produced
Table 2. Information at follow-up on participants included in the analysis*
Proportions
Variable Cases/N %
Female 1110/1955 56.8
Asthma 761/1955 38.9
Nasal allergies 969/1940 49.9
IgE sensitisation to Timothy grass 464/1926 24.1
SPT for: Timothy grass 536/1854 28.9
SPT for: any house dust mite 436/1855 23.5
SPT for: any allergen in list 973/1808 53.8
Distributions
Variable N Median (IQR) Range
Follow-up questionnaire age (years) 1955 49 (36, 60) 16–77
Leptin (pg/mL) 1955 12737.633 (5830.236, 28519.281) 0.001–211592.393
Adiponectin (ng/mL) 1794 9314 (6238, 14 023) 85–60 439
Leptin/adiponectin ratio (pg/ng) 1794 1.385 (0.585, 3.321) 0.000–787.536
Body mass index (k/m2) 1942 26.1 (23.2, 29.5) 15.8–53.5
Waist circumference (cm) 1826 92.0 (80.8, 101.5) 58.7–139.1
Waist/hip circumference ratio 1750 0.88 (0.80, 0.95) 0.60–1.36
Waist/height ratio (%) 1824 53.7 (47.7, 59.4) 35.6–86.5
Means
Variable N Mean (SD)
ECRHS 5-point asthma score 1616 1.46 (1.50)
*These statistics are for the sample and are not corrected to the population using sampling-probability weights.
SPT, skin prick test; ECRHS, European Community Respiratory Health Survey.
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inconsistent results. Using information from adults sur-
veyed as part of the National Health and Nutrition
Examination Survey in USA, Sood et al. [9] reported
strong associations of physician-diagnosed asthma with
leptin in women (but not men), with the associations
being much stronger in those who were under the age
of 50 (that is, assumed to be premenopausal). Sood
et al. also observed that the strength of these associa-
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Somers’ D (Propensity−adjusted (1), with 95% CI) of exposure with respect to outcome
Graphs by Outcome and Gender
Fig. 2. Somers’ D of associations of fatness measures and adipokine measures with asthma, nasal allergies, and atopy with adjustment for con-
founders only (propensity score 1).
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tions varied depending on what adjustment for ‘fatness’
was included in the analysis. Correction for triceps skin-
fold thickness made little difference, but inclusion of a
term for BMI abolished the apparent association. Suth-
erland et al. [11] found little evidence that leptin (or
adiponectin) levels were associated with asthma,
wheeze, and lung function in 32-year-old men or
women taking part in the Dunedin cohort study. Adjust-
ment for percentage body fat made little difference to
the overall conclusion. In the Cardiovascular Risk in
Young Finns Study, Jartti et al. [12] showed an associa-
tion of asthma with leptin in adults aged 24–39 years,
but this association was not present after adjustment for
several factors including BMI. They concluded that lep-
tin played little role in asthma.
We found no conclusive cross-sectional association
of any of the health outcomes with adiponectin level.
The CARDIA study [10] showed similar adiponectin
Table 3. Unadjusted, confounder-adjusted and mutually adjusted means for ECRHS 5-point asthma score in women by adipokine tertiles and fat-
ness groups, with Somers’ D for trend
Outcome and adjustment type N
Tertile means
Somers’ D (95% CI) P1 2 3
Adipokines
Leptin (pg/mL)
Unadjusted 936 0.56 0.69 0.98 0.20 (0.08, 0.30) 0.00079
Propensity-adjusted (1)* 872 0.55 0.66 0.97 0.19 (0.06, 0.32) 0.0055
Propensity-adjusted (2)† 775 0.60 0.65 0.92 0.14 (0.01, 0.28) 0.062
Adiponectin (ng/mL)
Unadjusted 853 0.82 0.75 0.71 0.07 (0.18, 0.03) 0.18
Propensity-adjusted (1) 797 0.76 0.74 0.69 0.08 (0.21, 0.06) 0.27
Propensity-adjusted (2) 715 0.79 0.73 0.72 0.10 (0.23, 0.04) 0.16
Leptin/adiponectin ratio (pg/ng)
Unadjusted 853 0.55 0.82 0.94 0.18 (0.07, 0.28) 0.0014
Propensity-adjusted (1) 797 0.53 0.73 0.97 0.16 (0.02, 0.29) 0.03
Propensity-adjusted (2) 715 0.56 0.82 0.91 0.14 (0.02, 0.29) 0.077
Outcome and adjustment type N
Group means
Somers’ D (95% CI) P1 2 3 4
Fatness measures
Body mass index (k/m2)
Unadjusted 932 0.84 0.52 0.71 1.20 0.14 (0.03, 0.25) 0.012
Propensity-adjusted (1) 868 0.79 0.50 0.74 1.15 0.15 (0.02, 0.28) 0.025
Propensity-adjusted (2) 794 1.26 0.60 0.65 0.98 0.03 (0.19, 0.12) 0.68
Waist circumference (cm)
Unadjusted 870 0.65 0.54 0.66 1.11 0.10 (0.01, 0.22) 0.082
Propensity-adjusted (1) 812 0.57 0.56 0.63 1.19 0.17 (0.02, 0.32) 0.028
Propensity-adjusted (2) 749 0.72 0.61 0.56 1.05 0.04 (0.18, 0.10) 0.56
Waist/hip circumference ratio
Unadjusted 832 0.62 0.56 0.91 0.88 0.12 (0.00, 0.25) 0.054
Propensity-adjusted (1) 776 0.55 0.54 0.92 0.99 0.15 (0.00, 0.30) 0.049
Propensity-adjusted (2) 716 0.69 0.60 0.82 0.90 0.07 (0.08, 0.21) 0.37
Waist/height ratio (%)
Unadjusted 869 0.59 0.52 0.71 1.16 0.15 (0.04, 0.27) 0.01
Propensity-adjusted (1) 811 0.54 0.53 0.65 1.28 0.19 (0.05, 0.32) 0.0065
Propensity-adjusted (2) 748 0.63 0.52 0.66 1.22 0.07 (0.08, 0.22) 0.34
*Adjusted for age and smoking history.
†Adjusted for age and smoking history and for fatness measures (in the case of adipokine exposures) and for adipokine exposures (in the case of
fatness measures).
Tertile cut-offs for adipokines in men: leptin (pg/mL) < 4556, 4556–10 191, 10 192+: adiponectin (ng/mL) < 6321, 6321–9926, 9927+: LAR (pg/
ng) < 0.5599, 0.5599–1.455, 1.456+.
Tertile cut-offs for adipokines in women: Leptin (pg/mL) < 13 704, 13 704–32 158, 32 159+: Adiponectin (ng/mL) < 8305, 8305–14 241,
14 242+: LAR (pg/ng) < 1.19, 1.19–3.359, 3.360+.
Group cut-offs for BMI: [0,20), [20,25), [25,30) and 30+ k/m2.
ECRHS, European Community Respiratory Health Survey.
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levels in those with and without self-reported asthma,
although in subgroup analyses there was a suggestion
of a protective role for asthma in pre-menopausal
women (even though formal testing to assess interac-
tions by menopausal status did not reach conventional
level of statistical significance). We investigated the
association of health outcomes with the leptin/adipo-
nectin ratio. This measure is associated with insulin
resistance in adults without diabetes [22] and is said to
predict the development of diabetes [23], but, like Jartti
et al. [12], we found the associations of asthma and
allergy with leptin/adiponectin ratio broadly mirrored
the associations seen for leptin.
If there are effects of leptin (and other adipokines) on
asthma, their high correlation with obesity makes it dif-
ficult to assess their independent role. Furthermore, the
causal pathway is not clear. Obesity is referred to as a
‘leptin resistant’ condition, and leptin is produced by
adipocytes (therefore high BMI causes high leptin lev-
els). However, leptin is also part of negative feedback
loop which suppresses appetite and increases metabolic
rate (therefore leptin levels influence BMI). When mea-
sures of fatness and adipokines are made at a single
time point, it is not entirely clear whether it is appro-
priate to adjust one for the other, although this is
widely carried out in research of metabolic disorders.
Epidemiologists examining the associations of breast
cancer [24], hypertension [25], and diabetes [26] with
obesity and adipokines have also commented on the
difficulty in disentangling their effects. This makes any
level of causal inference difficult, and we cannot pro-
vide any evidence to support the notion that an inter-
vention that would block the immunological effects of
adipokines (without blocking their slimming or fatten-
ing effects) would influence development of asthma or
atopy. Equally, we cannot say (from our data alone)
that weight reduction without related changes in
adipokine levels would reduce asthma.
Our study is cross-sectional, and as explained in the
previous paragraph, we are unable to confirm the
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temporal pattern of the associations observed. Response
rates to the postal survey were fair but not high, and
we have previously shown that women and older adults
were more likely to respond to the survey [14]. There
was no evidence that those with symptoms were more
likely to respond [14]. Associations observed were simi-
lar in centres with high and low response rates, and as
only complex response biases can give rise to biased
associations in population studies, we believe the asso-
ciations we report are representative of those seen in
European adult populations. We have used sophisticated
but appropriate statistical techniques to account for the
multi-centre case–control design of the study, to adjust
for relevant confounders, and to allow for multiple test-
ing. We have used propensity scores (which offer a sta-
tistically efficient approach for facilitating model
convergence when some subgroups are small) to adjust
for factors of interest. We have presented associations
using Somers’ D (and its 95% confidence interval),
which allowed a common metric for multiple testing
with outcomes that have binary or negative binomial
distributions (such as the asthma score). As with all
parameters, highly statistically significant estimates
may represent small, clinically irrelevant differences,
but Somers’ D is a good measure for overall ordinal
association. We have conducted multiple tests and cor-
rected for this. Ideally, we would have investigated
some associations using meta-analyses of each centre’s
data and including testing of interaction terms for men-
opausal status in women, but our study, although large,
has limited statistical power for such approaches.
In our study, leptin and adiponectin levels were
tested on non-fasting samples. As leptin [27] and
adiponectin [28] change little following ingestion of
food, it is unlikely that our failure to observe strong
associations is influenced by random error related to
recent ingestion of food.
To our knowledge, no one has reported associations
of leptin with rhinitis, and there has only been one
epidemiological study of the relationship of allergic
sensitisation with adipokines [13] in adults (showing
some evidence of a more sensitisation with increasing
leptin levels). One further study has reported that lep-
tin was not associated with sensitisation in children
[29]. There was no convincing evidence in our data
that strong associations exist between obesity/adipo-
kines and these markers of atopy. Higher leptin levels
in men were associated non-significantly with a lower
prevalence of nasal allergies, but there were no strong
associations with sensitisation to Timothy grass. Our
study does not support previous work in mice, sug-
gesting that leptin plays a role in the allergic response
[30]. If obesity and adipokines are associated with
asthma, but not atopy, as suggested by our analysis,
we would expect that there will be stronger associa-
tions of obesity and adipokines with ‘non-atopic
asthma’ than with ‘atopic asthma’, as shown and dis-
cussed in other publications [31, 32]. In our post hoc
analyses, we saw little evidence for such a difference,
although this multi-centre study was too small to fully
explore these associations.
In summary, we have shown that, in both men and
women, asthma is associated with leptin and leptin/
adiponectin ratio, but we were unable to clearly show
that this is independent of the relationship of asthma
with obesity. This cross-sectional epidemiological study
provides little evidence that changes in endogenous
leptin or adiponectin levels, without related changes in
fatness, would have any benefit for asthma.
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